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Abstract
Pulmonary colonization of cystic fibrosis (CF) patients with Burkholderia cenocepacia or other bacteria of the Burkholderia
cepacia complex (Bcc) is associated with worse prognosis and increased risk of death. During colonization, the bacteria may
evolve under the stressing selection pressures exerted in the CF lung, in particular, those resulting from challenges of the
host immune defenses, antimicrobial therapy, nutrient availability and oxygen limitation. Understanding the adaptive
mechanisms that promote successful colonization and long-term survival of B. cenocepacia in the CF lung is essential for an
improved therapeutic outcome of chronic infections. To get mechanistic insights into these adaptive strategies a
transcriptomic analysis, based on DNA microarrays, was explored in this study. The genomic expression levels in two clonal
variants isolated during long-term colonization of a CF patient who died from the cepacia syndrome were compared. One of
the isolates examined, IST439, is the first B. cenocepacia isolate retrieved from the patient and the other isolate, IST4113, was
obtained three years later and is more resistant to different classes of antimicrobials. Approximately 1000 genes were found
to be differently expressed in the two clonal variants reflecting a marked reprogramming of genomic expression. The up-
regulated genes in IST4113 include those involved in translation, iron uptake (in particular, in ornibactin biosynthesis), efflux
of drugs and in adhesion to epithelial lung tissue and to mucin. Alterations related with adaptation to the nutritional
environment of the CF lung and to an oxygen-limited environment are also suggested to be a key feature of transcriptional
reprogramming occurring during long-term colonization, antibiotic therapy and the progression of the disease.
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Introduction
The Burkholderia cepacia complex (Bcc) is a heterogeneous group
of bacteria comprising at least 17 closely related species that are
ubiquitous, metabolically versatile and can cause chronic oppor-
tunistic infections in immunocompromised patients and in patients
with cystic fibrosis (CF) [1]. In general, these bacteria lead to long-
term colonization and to a more rapid decline in lung function of
these patients and in some cases to the development of a fatal
necrotizing pneumonia, accompanied by septicemia, known as the
‘‘cepacia syndrome’’[1]. Bcc bacteria are often resistant to the
most known clinically used antibiotics [1,2,3]. This trait and the
ability to develop high-level resistance during antibiotic treatment
and to adapt and resist to other adverse environmental conditions
severely hinders the effective treatment of respiratory infections
rendering their eradication from the CF lung very difficult, if not
virtually impossible [1,2]. During chronic colonization of the
airways of CF patients, Bcc bacteria experience changing selection
pressures, in particular those resulting from challenges of the
immune defenses, antimicrobial therapy, nutrient availability and
oxygen limitation [4]. The adaptive responses occurring in clinical
isolates of Pseudomonas aeruginosa, another major respiratory
pathogen of CF patients [5], have been on the focus of recent
studies [6,7,8,9,10,11,12] but equivalent studies on Bcc bacteria
are still lacking. Based on the collection of Bcc isolates gathered
since 1995, as the result of systematic and longitudinal
epidemiological surveys carried out by our group for the past 16
years of the respiratory infections of CF patients by Bcc followed at
the major Portuguese CF Center, in Santa Maria Hospital (HSM)
in Lisbon [3,13,14], we have been trying to get clues on the
adaptive strategies adopted by B. cenocepacia during chronic
infection. Our analysis was based on extensive phenotypic,
genotypic and genome-wide expression approaches focusing
selected Bcc isolates obtained during chronic colonization of
different patients [3,15,16 and unpublished results]. In particular,
we performed the systematic assessment of a number of relevant
phenotypic characteristics in the context of CF infections, of eleven
serial isolates obtained from a CF patient colonized during three
and a half years until the patient’s death with the cepacia
syndrome [15]. These isolates are indistinguishable based on the
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same clonal Based Upon Related Sequence Types (BURST) group
[15], consistent with the idea that the CF patient’s lungs can be
chronically colonized for years by one or a few lineages of P.
aeruginosa and Bcc bacteria [17,18,19,20]. This systematic
phenotypic analysis suggested the occurrence of clonal expansion
of B. cenocepacia during chronic lung infection presumably as the
result of mutations and selective pressures occurring in the CF
lung environment, in particular due to host immune defenses,
antibiotic therapy and oxygen limitation, as proposed for P.
aeruginosa [6,7,9,10,11,19,21].
The present study is dedicated to the comparison of the
genomic expression, based on DNA microarrays, of two of these
11 sequential B. cenocepacia isolates: isolate IST439 that was the first
B. cenocepacia isolate retrieved from the patient and thought to have
initiated the infection with this bacterium, and isolate IST4113
that exhibits increased levels of resistance to different classes of
antimicrobials and was obtained three years later, after a period of
exacerbated pulmonary infection that compelled the patient to
hospitalization and intravenous therapy with gentamicin and
ceftazidime [3,16]. The proteomes of these same isolates were
quantitatively compared before, based on two-dimensional gel
electrophoresis (2-DE) using DIGE technology (Difference Gel
Electrophoresis) [16]. Proteins of the functional categories Energy
metabolism, Translation, Iron uptake, Nucleotide synthesis and
Protein folding and stabilization were more abundant in IST4113,
compared to IST439, suggesting an increased protein synthesis,
DNA repair activity, iron uptake capacity and stress resistance in
isolate IST4113 [16]. The concentration of proteins related with
peptidoglycan biosynthesis and the synthesis of membrane lipids
and of lipopolysaccharide was also found to be different in the two
clonal variants [16]. Since protein coverage based on the
quantitative proteomic analysis performed is limited, the here
described transcriptomic analysis complements and extends the
indications obtained before enlightening the genome-wide adap-
tive strategies of B. cenocepacia to adapt to cystic fibrosis patients’
airways and antibiotic therapy during long-term colonization.
Results
Comparative analysis of the transcriptomes of B.
cenocepacia isolates IST439 and IST4113
To compare the transcriptomes of Burkholderia cenocepacia
IST439, thought to have started the infection of a cystic fibrosis
(CF) patient with B. cenocepacia, and the clonal variant IST4113,
retrieved three years later and exhibiting an increased resistance to
all the antimicrobials tested [3,15,16], total RNA was extracted
from cells cultivated for 24 hours onto the surface of LB plates, at
37uC, to mimic bacterial growth during chronic colonization of
the CF patient’s lung. These same conditions were used before to
quantitatively compare the proteomes of these two isolates [16].
This microarray analysis indicated that, using a 1.5-fold threshold
value, 1024 genes are differently expressed in the two variants, 534
genes being up-regulated and 490 genes down-regulated in the
IST4113 variant, compared to IST439. A selected sub-set of the
differently expressed genes in the two variants is shown in
Supplementary Table S1 while the complete list is provided in
supplementary tables S2 and S3.
The 1024 genes found to have an altered transcription in
IST439 and IST4113 are distributed through the three B.
cenocepacia chromosomes, ranging from 5 to 9.3% of the coding
sequences present in each chromosome (Table 1). Almost one half
of our microarray dataset of genes differently expressed in IST439
and IST4113 (474 genes out of 1024) corresponds to genes located
in chromosome 1, containing genetic information for central
metabolism and other core cellular functions [22]. Only one of the
genes differently expressed in the two clonal variants (pBCA015)
was found to be located in the natural plasmid pBCJ2315 (Table 1).
Three of the genes more actively transcribed in IST4113,
compared to IST439, are located within the cci pathogenicity
island, a conserved DNA region among B. cenocepacia epidemic
strains and involved in infection and antibiotic resistance [22].
These three genes encode a putative ion transporter (BCAM0238),
a N-acylhomoserine lactone-dependent regulatory protein (cciR)
and a gene of unknown function (BCAM0243) [23]. No other gene
located in the described genomic islands present in B. cenocepacia
J2315 genome was found to be differently expressed in the clonal
variants examined, consistent with the concept that B. cenocepacia
pathoadaptation to CF lung relates with modifications occurring at
the level of the inherent traits of the bacterium instead of being
acquired through mobile genetic elements [24].
The microarray used in the transcriptomic analysis carried out
includes probes for the detection of coding sequences (CDSs) of the
J2315 epidemic strain, as well as for CDSs that are absent in this
strain but present in the genome of two other sequenced strains,
AU1054 (recovered from the blood of a CF patient) and HI2424 (a
soil isolate) [24]. Eight genes specific of the AU1054 strain were
found in our study among the genes differently expressed in the
two variants. Three of these genes (Bcen_1448, Bcen_1449 and
Bcen_2828) are up-regulated in IST4113 while five of these genes
(Bcen_2651, Bcen_2885, Bcen_2886, Bcen_2900 and Bcen_3131) are
more actively transcribed in IST439 (Supplementary Tables S2
and S3). Although these DNA regions are absent from J2315
genome, the two clonal variants examined, isolated in Portugal,
belong to the same clonal complex as J2315 (complex 31) [15,25]
whereas strain AU1054 belongs to clonal complex 125 [25]. The
transcript levels of B. cenocepacia HI2424-specific genes present in
the DNA microarray used were identical in IST439 and IST4113.
The genes found to have an altered expression in IST439 and
IST4113 were clustered according to their physiological function,
usingtheinformationavailableintheBurkholderia GenomeDatabase
(http://www.burkholderia.com/) and in the KEGG pathways
database (http://kegg.jp/kegg) (Fig. 1). Among the 1024 differently
Table 1. Distribution of the genes differently transcribed
(above or below a 1.5-fold) in IST439 and IST4113 through the






Chromossome 1 248 (7.0%) 226 (6.4%)
Chromossome 2 187 (6.5%) 224 (7.8%)
Chromossome 3 72 (9.3%) 39 (5.0%)
Plasmid 10
tRNAs 26 1
Intergenic regions 48 66
The genes found to be differently transcribed in IST439 and IST4113 variants,
according with the microarray analysis carried out, were distributed through
the 3 chromosomes and one plasmid (pBCJ2315) that compose the genome of
B. cenocepacia J2315 strain [22]. Inside brackets it is indicated the percentage of
genes differently transcribed in the two clonal variants, considering a total of
3537, 2849 and 776 coding sequences for chromosomes 1, 2 and 3, respectively
[22]). The number of tRNAs, rRNAs and intergenic sequences (IGs) that exhibit
altered transcript levels in the two variants is also indicated.
doi:10.1371/journal.pone.0028831.t001
B. cenocepacia Transcriptome Variation in CF Lungs
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were clustered as ‘‘Unknown’’. An enrichment of genes involved in
protein synthesis, ion homeostasis (in particular, in iron uptake) and
sulphur metabolism is evident among the genes with higher
transcript levels in the IST4113 variant. The functional categories
‘‘Transport’’ and ‘‘Cell envelope and outer membrane’’ are also
enriched in the dataset of genes transcriptionally activated in
IST4113, although less significantly. The functional classes having a
higher number of genes more actively transcribed in IST439 are
‘‘Replication, transcription and transcriptional regulation’’, ‘‘Stress
response’’, ‘‘Signalling’’, ‘‘Protein trafficking and secretion’’ and
‘‘Protein folding and modification’’ (Fig. 1). The genes involved in
stress response found to be up-regulated in IST439 encode
essentially proteins involved in response to oxidative stress, namely
four enzymes involved in glutathione biosynthesis (BCAL0639,
BCAL1250,BCAM0590andBCAL3331), athioredoxin (BCAL0463),
a peroxiredoxin (BCAL2013), the glutathione peroxidase Gpo and
the peroxidase/catalase KatB (Supplementary Table S2). More-
over, the transcript level of
70s-factor EcfA2, an RpoE-like
regulator presumed to control the expression of genes required for
response to heat and oxidative stress [26], in IST4113 cells are half
of those registered in IST439 (Supplementary Table S3). Consis-
tently, several components of the GroEL chaperone complex, also
predicted to be regulated by the
70s-factor EcfA2 [26], are down-
regulated (in a range from 3.1 to 29-fold) in IST4113 cells
(Supplementary Table S3). The other functional classes include a
similar number of genes of the microarray dataset (Fig. 1) but,
although clustered in the same class, the genes differently
transcribed in the two variants have different functions (Supple-
mentary Tables S2 and S3). For example, the genes clustered in the
‘‘Motility and adherence class’’ up-regulated in IST4113 are related
with the biosynthesis and assembly of flagella (flhB, flhF, fliK, fliJ,
fliG, fliN, flgB, flgD, flgE, flgF, flgG, flgH and flgI) while the genes
clustered in this same functional class that are up-regulated in
IST439 relate with chemotaxis (flhD, motA, motB, cheY, tar,
BCAL0136). A detailed description of selected functional groups of
genes differently expressed in IST439 and IST4113 follows.
Genes involved in translation are up-regulated in the
clonal variant more resistant to antibiotics targeting this
cellular process
The clonal variant IST4113 is significantly more resistant
than IST439 to the aminoglycosides tobramycin (MIC of
512 mgm L
21, compared to 128 mgm L
21) and gentamicin
(MIC of 1400 mgm L
21, compared to 130 mgm L
21) [15,16] that
target protein synthesis. Eighty-six genes related with translation
were found to be more actively transcribed in IST4113, compared
to IST439, including components of the large and small ribosome
subunits and initiation and elongation factors (Supplementary
Table S1). These genes are distributed throughout the several
rRNA operons present in chromosome 1 (Fig. 2). The levels of a
significant number of tRNAs were also found to be higher in
IST4113 (Supplementary Table S2) reinforcing the idea that
translation is a more active process in this clonal variant.
Figure 1. Clustering, based on biological function, of the genes found to be differently expressed in IST4113 (black bars) or in
IST439 (white bars). The genes whose transcript level in the two variants varied above 1.5-fold were selected and grouped according to their
biological function, based on the information available in the Burkholderia Genome database and in the KEGG Pathways Database.
doi:10.1371/journal.pone.0028831.g001
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differently expressed in IST439 and IST4113
Besides being more resistant to aminoglycosides, the clonal
variant IST4113 is also more resistant than IST439 to all the
antimicrobials of the different classes tested, including the b-
lactams piperacillin, tazobactam, ceftazidime and imipenem; the
fluoroquinolone ciprofloxacin and the folate-pathway inhibitors
trimethoprim-sulfamethoxazole [15,16]. This increased antibiotic-
resistance phenotype of IST4113 prompted us to search for genes
previously related with antimicrobial resistance within the
microarray dataset (Table 2). Among the potential drug resistance
determinants identified before in the genome of B. cenocepacia
J2315 [22], nine are differently expressed in IST439 and IST4113
(Table 2). Those up-regulated in IST4113 include mdtABC and
bpeA, whose products are two pumps of the resistance nodulation-
division (RND) family; BCAM0201, a drug pump of the Major
Facilitator Superfamily (MFS); and BCAM2188, encoding a
component of an ABC-transporter thought to be involved in the
extrusion of macrolides (Table 2). Remarkably, the elimination of
bpeA was proved to increase B. cenocepacia susceptibility to
gentamicin, tobramycin and ciprofloxacin [27]. The transcript
levels of BCAM0791, predicted to encode a multidrug MFS efflux
pump, were also found to be higher in IST4113 than in IST439
(Table 2). The higher transcription level of a number of these drug
pump-encoding genes in IST4113 variant was confirmed by qRT-
PCR (Table 2). Although the transcript levels of most of these
genes vary in the two variants from 1.5 to 2.3-fold only, minor
changes in the expression of bacterial drug pumps have impact in
drug resistance [28,29,30]. The quantification of the intracellular
accumulation of the fluorescent dye ethidium bromide in the two
clonal variants reinforce the idea that IST4113 is able to extrude
drugs more actively than IST439, given that IST4113 cells
accumulate a lower amount of ethidium bromide than IST439
cells after 24 h of cultivation at 37uC in LB plates (Fig. 3). The
transference of both culture plates to 4uC, a temperature known to
drastically inhibit the activity of MDR pumps, led to a similar
accumulation of the dye in the two isolates (Fig. 3), consistent with
the proposed higher drug active export capacity of IST4113 cells.
Multiple antibiotic resistance in Bcc bacteria has also been
related with the expression of antibiotic modifying enzymes and
reduced permeability of the outer membrane [1,2,31,32].
However, the transcript levels from the four b-lactamases encoded
by J2315 genome (BCAM0393, BCAM1779, BCAM2165 and
BCAS0156) are identical in the two variants and no alteration was
registered in the transcript levels from genes encoding enzymes
required for inactivation of aminoglycosides (the aminoglycoside-
3-phosphotransferase BCAM0928 and the aminoglycoside-39ade-
nyltransferase BCAM1013A). The transcription of a penicillin-
binding protein (PBP), BCAM1738, and of a PBP-precursor,
BCAL2205, was down-regulated (by 1.8 and 1.6-fold, respectively)
in IST4113 (Table 2). Since ceftazidime and piperacillin directly
target PBP activity, the lower expression of these two genes is likely
to favour IST4113 resistance to these antibiotics.
The reduced permeability of B. cenocepacia outer membrane
registered in cells adapted or intrinsically resistant to antibiotic
stress has been mainly related with the down-regulation of porins
and with a reduced content of 3-deoxy-D-manno-octulosonic-acid
and phosphate in the lipopolysaccharide (LPS), a modification of
the cell surface that leads to the decrease of binding sites for
cationic antibiotics thus preventing their diffusion to the
intracellular environment [1,31,32]. Remarkably, the transcript
level of the waaA gene, whose product catalyses the transference of
3-deoxy-D-manno-octulosonic-acid into lipid A, is reduced in
IST4113 (Table 2) suggesting the presence of a more positive LPS
in IST4113 cells compared to IST439 cells. This hypothesis is also
consistent with the higher resistance levels of IST4113 to cationic
aminoglycosides [16]. Ten genes encoding outer membrane porins
(ompA, BCAL1076, BCAL1829, BCAL2645, BCAL3008, BCAL3473,
BCAM1787, BCAM1931, BCAM1015 and BCAS0460) were found
to be down-regulated in IST4113, compared to IST439, and the
lower transcript levels of some of these genes in IST4113 cells was
confirmed by qRT-PCR (Table 2). Notably, BCAM1931 is highly
homologous (89% identity) to the B. cepacia outer membrane porin
Opcp1, through which b-lactams can diffuse into the cytosol [32]
and BCAL3008 and BCAM1931 are similar (30% identity) to the E.
coli porins OmpF and OmpC, respectively, that also serve as
Figure 2. Genetic organization of genes related with translation (ribosomal genes and translation initiation factors) found to be up-
regulated in the IST4113 variant, compared to IST439. Black arrows indicate the genes with higher transcript levels in IST4113 than in IST439
whereas white arrows indicate those equally transcribed in the two variants. The localization of the genes in the genome is provided using the
genome of the sequenced J2315 as a reference, according with the information available in the Burkholderia Genome Database. Genes marked with
an asterisk are not related with translation.
doi:10.1371/journal.pone.0028831.g002
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membrane porins whose expression is suggested to be reduced in
IST4113 was previously associated with antibiotic resistance in B.
cenocepacia.
Metabolic adaptation of B. cenocepacia during long-term
colonization of a CF patient
Approximately 20% of the genes differently expressed in the
clonal variants herein examined are related with cellular metabolic
activity: 101 genes are involved in the metabolism of carbohydrates,
54inthemetabolismofaminoacidsandothernitrogencompounds,
22 in lipid metabolism, 13 in the metabolism of sulphur compounds
and 10 genes are related with nucleotide metabolism (Fig. 1,
Supplementary Table S1 and Supplementary Tables S2 and S3).
Such a high number of genes related with metabolic functions being
differently transcribed in IST439 and IST4113 indicates that an
extensive metabolic adaptation has occurred during the coloniza-
tion period that separates the dates of isolation of these two variants.
The most relevant adaptive responses suggested by this transcrip-
tomic analysis are detailed below:
i) Central carbon metabolism and energy
production. The genes related with central carbon
metabolism that have an altered expression in the clonal
variants IST439 and IST4113 were clustered according to the
metabolic pathways in which they are involved, using the KEGG
pathways database (Fig. 4). Genes encoding enzymes involved in
the catabolism of citrate, fructose, acetoin, N-acetylglucosamine
and 2-keto-3-deoxygluconate and genes encoding transporters
required for the uptake of these same sugars were found to be up-
regulated in IST4113 (Fig. 4, Supplementary Table S1 and
Supplementary Table S2). Two enzymes of the glyoxylate cycle,
isocitrate lyase (BCAM1588) and malate synthase (aceB), are also
more actively transcribed in IST4113 cells (Fig. 4 and
Supplementary Table S1) suggesting an increased flux of this
anaplerotic pathway in this clonal variant, compared to IST439.
The genes down-regulated in IST4113 that were clustered in
‘‘carbohydrate metabolism’’ functional class include those involved
in phenylacetate catabolism (paaD, paaC, paaK, paaI, paaG, paaF,
paaZ and BCAM2568), Krebs cycle (BCAL2746, BCAM0964, acnB
and mdh) and electron transport (Supplementary Table S1,
Table 2. Antibiotic resistance-genes differently transcribed in IST439 and IST4113.
CDS/Gene Function mRNA IST4113/mRNA IST439
Microarray analysis qRT-PCR
Chromossome 1
BCAL1079/mdtA Multidrug efflux transporter of the Resistance Nodulation Family (known as RND6) 1.6 1.5
BCAL1079/mdtB 1.6 2.2
BCAL1079/mdtC 1.7 7.0
BCAL2822/bpeA Subunit of the drug efflux transporter RND4 1.6 -
BCAL1076/ompA Outer membrane protein 21.7 -
BCAL1510 Outer membrane protein 22.3 -
BCAL1511/emrA Putative multidrug resistance transporter 21.7 -
BCAL1829 Outer membrane protein 25.3 -
BCAL2205 D-alanyl-D-alanine endopeptidase (penicillin-binding protein precursor) 21.6 -
BCAL2645 Outer membrane protein; has some similarity with P. aeruginosa OprF 22.3 -
BCAL2958/ompA Outer membrane protein 21.8 -
BCAL3008 Outer membrane protein; has some similarity with P. aeruginosa OprE 25.2 -
BCAL3110/waaA Protein involved in incorporation of 3-deoxy-D-manno-octulosonic-acid in lipid A during LPS
biosynthesis
21.6 -
BCAL3473 Outer membrane protein 21.6 -
Chromossome 2
BCAM0201 MFS efflux transporter 1.6 1.7
BCAM2188 Component of a putative macrolide-specific efflux transporter 2.2 -
BCAM0791 MFS efflux transporter 2.3 2.2
BCAM1015 Outer membrane protein 22.7 -
BCAM1738 Putative penicillin-binding protein 21.8 -
BCAM1787 Outer membrane protein 21.7 -
BCAM1931 Outer membrane protein; homologous to B. cepacia Opcp1 23.4 -
BCAM2385/arr Rifampin ADP-ribosyl transferase 21.7 -
Chromossome 3
BCAS0016 Transporter of the fusaric acid resistance family 22.0 -
BCAS0460 Outer membrane protein 22.1 27.5
The microarray dataset of genes differently transcribed in IST439 and IST4113 was searched for antibiotic-resistance determinants identified by Holden et al., 2009 and
Bazzini et al., 2011. To confirm the results obtained in the microarray analysis, the transcript levels from some of the genes listed were compared by quantitative real
time RT-PCR (qRT-PCR).
doi:10.1371/journal.pone.0028831.t002
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subunits of two cytochromes with a low affinity to oxygen
(cyoABCD, encoding subunits of cytochrome o and petABC whose
products are three subunits of ubiquinol-cytochrome-c reductase)
were found to be repressed in IST4113 (Supplementary Table S1
and Supplementary Table S3). In contrast, BCAM2674 and
BCAM2675 genes, which encode two homologues of P. aeruginosa
cytochrome CioAB, demonstrated to have a high affinity for
oxygen and to serve as electron donor to this gas under
microaerophilic conditions [34], were found to be up-regulated
in IST4113 cells by 2.7- and 1.6-fold, respectively (Supplementary
Table S1).
ii) Amino acid and nitrogen metabolism. The transcript
levels of 46 genes encoding ABC transporters involved in the
uptake of amino acids and oligopeptides, as well as of genes
involved in the metabolism of amino acids into sugar precursors,
are higher in IST4113 than in IST439 (Fig. 4, Supplementary
Table S1 and Supplementary Table S2). Since it is known that
amino acids are present at high concentrations in the sputum of
CF patients, especially after periods of exacerbated bacterial
infection [35,36], this transcriptional response may reflect the
long-term adaptation of B. cenocepacia to the nutritional
environment of the CF lung. The up-regulation of genes related
with the uptake of amino acids was also observed when B.
cenocepacia was cultivated in the presence of CF sputum [24].
Furthermore, three genes involved in the reduction of ammonium
into amino acids were also found to be up-regulated in IST4113:
glnA, encoding glutamine synthethase; BCAS0014, encoding a
predicted histidine ammonia-lyase and gcvT, encoding a
component of the glycine aminomethyltransferase system (Fig. 4).
iii) sulphur metabolism. The transcription of the three
genes of the tauABC operon, which encodes the ABC-transporter
for the sulphur-containing amino acid taurine, whose
concentration is high in CF patients’ sputum [37], and of four
genes encoding taurine dioxygenases (tauD, BCAM1121,
BCAM1122, BCAM1123), required for the reduction of taurine
into sulfite, was found to be up-regulated in IST4113
(Supplementary Table S1; Fig. 5). Genes involved in the uptake
and metabolization of monoalkanesulphonates are also more
actively transcribed in IST4113 (Fig. 4) while the genes of the
sulphate metabolism cluster (cysN, cysD1, cysH, sbp, cysT and cysW)
have reduced transcript levels in these same cells, compared to
IST439 (Supplementary Table S1 and Fig. 5). Interestingly, many
natural sulphonates are known to be present in the surface of
epithelial lung cells and in mucin [38] and clinical isolates of B.
cenocepacia were found to have a high mucin sulphatase activity
[39].
Genes involved in iron uptake are up-regulated in the
IST4113 isolate
The transcription of seven out of the twenty genes that compose
the two operons of the ornibactin biosynthetic cluster were found
to be up-regulated in IST4113, compared to IST439 (Supple-
mentary Table S1). Although the orbI gene belongs to the same
transcription unit as orbJ and orbK [40], only these two last genes
were identified in our dataset as being transcriptionally activated
in the IST4113 variant (Supplementary Table S1). However,
qRT-PCR experiments showed that the transcript levels of orbI
gene are also higher in IST4113 cells (results not shown). Notably,
results from previous studies suggest that ornibactin biosynthesis is
essential in B. cenocepacia colonization of the lungs of a CF rat
model [41]. Other genes involved in iron uptake were also found
to be transcriptionally activated in IST4113 including BCAL1371,
BCAM0564 and BCAM1571, which encode three TonB-depen-
dent receptors of iron-siderophores, and huvA and hmuS, which
encode two of the four genes of a cluster dedicated to the uptake of
heme or hemin.
Figure 3. Indirect comparison of the active drug export capacity of IST439 and IST4113, based on the ethidium bromide screening
agar method. Cells of the two clonal variants were harvested in mid-exponential phase of growth and spread, in duplicate, onto the surface of LB
plates supplemented or not with ethidium bromide, as detailed in Materials and Methods. The plates were incubated for 24 h at 37uC and the
fluorescence values emitted by the cell mass present in each plate were quantified. One set of plates was left to grow for an additional period of 4 h
at 37uC while the other set was transferred to 4uC, a temperature at which the activity of MDR pumps is significantly reduced. The results obtained are
representative of at least three independent experiments.
doi:10.1371/journal.pone.0028831.g003
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differently expressed in the two variants
The transcription levels from several genes thought to be
virulence determinants in B. cenocepacia are different in IST439 and
IST4113 (Table 3). The virulence-related genes up-regulated in
IST4113 include two adhesins (BCAM0219 and BCAM0223), a
flavohemoprotein (hmpA), the enzymes of the ornibactin biosyn-
thetic pathway and the quorum sensing-regulated transcription
factors cciR and shvR. On the other hand, twenty-six known
virulence genes have a reduced transcription level in the IST4113
variant including the exoproteases ZmpA and ZmpB, two secreted
phospholipases (plcN and BCAM0408), several components of type
III and type VI secretion systems, two enzymes involved in LPS
biosynthesis (waaA and wbxY), the
54s factor RpoN and the cable
pili adhesin adhA (Table 3).
Beside the two above referred adhesins, the transcript levels
from a number of other genes related with adhesion were also
higher in the IST4113 variant, including the lectins bclB and bclC
that mediate bacterial attachment to mucin [42,43,44] and several
genes related with the assembly of flagella (flhB, flhF, fliG, fliK, fliJ,
fliN, flgB, flgD, flgE, flgF, flgG, flgH, flgI) which was found to play an
essential role in the initial steps of adhesion to epithelial cells [45].
In contrast, the transcript level of the major cable-pili adhesin adhA
[46] is lower in IST4113 than in IST439 (Supplementary Table
S1). Two genes of the O-antigen biosynthesis cluster, waaA and
wbxY, are down-regulated in IST4113, suggesting a decreased O-
antigen content in the LPS of these cells, compared to IST439
(Supplementary Table S1), consistent with the rough morphology
of IST4113 colonies and the smooth morphology of IST439
colonies [15,47]. Other relevant genes up-regulated in the
IST4113 variant include the GTP-binding exoprotease lepA, two
zinc metallo-endopeptidases, BCAL1671 and BCAM0180, the
periplasmic serine protease inhibitor ecotin (encoded by the eco
gene) and BCAM0550, a putative secreted lipase (Supplementary
Table S1). Interestingly, P. aeruginosa ecotin was suggested to play a
role in improving persistence of this bacterium in the CF lung by
protecting this bacterium against the activity of neutrophils
elastase [48].
Discussion
During chronic infections the airways of a patient with CF
represent an evolving system with multiple phenotypic variants
emerging from the clonal population and becoming established in
the patient’s airways [6,7,9,15,49]. These clonal variants may
result from genetic adaptation and selection pressures exerted by
Figure 4. Genes differently transcribed in IST439 and IST4113 related with the uptake and metabolism of carbohydrates and amino
acids, shown associated to the metabolic pathways in which they are involved. The metabolic map shown was prepared based on the
information available in the KEGG Pathways Database and using as the input dataset the genes clustered in the functional classes shown in Fig. 1
‘‘Transport’’, ‘‘Amino acid metabolism’’ and ‘‘Carbohydrate Metabolism’’. The genes that are more actively transcribed in IST4113 are shown inside
grey boxes whereas the genes that have a higher transcript level in the IST439 variant are indicated inside white boxes. Proteins known to be more
abundant in IST4113 than in IST439, based on the results of a previous expression proteomic analysis [16], are marked with an asterisk.
doi:10.1371/journal.pone.0028831.g004
B. cenocepacia Transcriptome Variation in CF Lungs
PLoS ONE | www.plosone.org 7 December 2011 | Volume 6 | Issue 12 | e28831the host environment, in particular, from the challenges imposed
by the immune defences, antimicrobial therapy, nutrient avail-
ability and oxygen limitation. Results from the transcriptomic
analysis described in this study provide important indications on
the adaptive strategies used by Burkholderia cenocepacia. The large
number of genes (above 1000) found to be differently expressed in
the two B. cenocepacia isolates examined, recovered in the beginning
of the infection (IST439) and after three years of chronic
colonization and lung deterioration (IST4113), reflects the marked
alteration of the genomic expression that occurred in these clonal
variants, as described before for P. aeruginosa [6,7,9,12].
The two variants examined belong to the same clonal complex
as B. cenocepacia J2315 [15] and harbour in their genome DNA
regions specifically found in this strain and in other members of
the epidemic ET-12 lineage, namely, the pathogenicity island cci.
One of the genes located in this pathogenicity island that is up-
regulated in IST4113 is the quorum-sensing (QS) regulator CciR
which plays a role in the persistence of B. cenocepacia infections [23],
suggesting that the transcription level of this gene and of two other
genes located in the pathogenicity cci island (BCAM0238 and
BCAM0243) may be enhanced during long-term colonization and
the progress of the disease.
An impressive number of genes related with bacterial
adaptation to the nutritional environment of the CF lung emerged
from this study as having an altered transcription during long-term
colonization. It is known that bacterial human pathogens
frequently adjust their metabolic pathways to sustain growth in a
hostile host-specific microenvironment [50]. The transcript levels
of genes encoding amino acid transporters or involved in amino
acid catabolism were higher in isolate IST4113, in line with
previous reports for P. aeruginosa [6,10,35,51,52,53]. During
chronic respiratory infections, B. cenocepacia cells grow and
proliferate within the viscous layers of the sputum present in the
patients’ lungs, a microenvironment with a complex nutrient
composition that includes a high concentration of amino acids
[35,52,53]. The transcript levels of three genes involved in the
reduction of ammonium into amino acids (glnA, gcvT and
BCAS0014) are also higher in the IST4113 variant, compared to
IST439, suggesting that B. cenocepacia may use a nitrogen-carbon
balancing mechanism dependent on ammonium reduction, similar
to the one reported for P. aeruginosa [54]. An increased activity of
the glyoxylate cycle in IST4113 is also hypothesized, based on the
higher transcript levels of isocitrate lyase- and malate synthase-
encoding genes registered in these cells, compared to IST439.
Moreover, the transcript levels of the RpoN s factor, known to
repress the glyoxylate pathway in P. aeruginosa [55], were lower in
IST4113 than in IST439. A higher activity of glyoxylate cycle at
later stages of the infection may allow the bacterium to use
available C2 substrates as the sole carbon sources, in particular,
the fatty acids present in surfactants existing in the CF lung [1].
Indeed, four genes encoding enzymes related with fatty acid b-
oxidation (phbA, BCAM2526, BCAS0346 and BCAS0419) are more
actively transcribed in IST4113 than in IST439 (Supplementary
Table S1). Interestingly, isocitrate lyase is considered an important
virulence factor in human-pathogenic bacteria because it allows
survival in the nutrient-depleted environment of the phagolyso-
some [56,57]. Although B. cenocepacia isolates retrieved from
chronically infected CF patients have been demonstrated to grow
inside macrophages [58], the role of isocitrate lyase and of the
glyoxylate cycle in this phenomenon has never been addressed.
Figure 5. Genes related with sulphur metabolism differently transcribed in IST439 and IST4113 cells. The metabolic map was prepared
based on the information available in the KEGG Pathways Database using as the input dataset the genes clustered in the functional classes shown in
Fig. 1 ‘‘Transport’’ and ‘‘Sulphur metabolism’’. The genes more actively transcribed in IST4113 are indicated inside grey boxes whereas the genes that
have a higher expression in IST439 are indicated inside white boxes.
doi:10.1371/journal.pone.0028831.g005
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CDS/Gene Function mRNA IST4113
mRNA IST439
Chromossome 1
BCAL1697/orbJ Ornibactin biosynthesis non-ribosomal peptide synthase 1.9
BCAL1698/orbK Ornibactin biosynthesis protein 3.0
BCAL1699/pvdA L-ornithine -oxygenase required for iron assimilation 4.9
BCAL1700/orbA Ornibactin receptor 5.9
BCAL1701/pvdF Ornibactin synthetase F 4.1
BCAL1702/orbL Putative ornibactin biosynthesis protein 3.1
BCAL3285/hmpA Flavohemoprotein associated to phenylacetate catabolism 1.5
BCAL0212/paaD Phenylacetic acid degradation protein PaaD 21.7
BCAL0341 Putative type VI secretion system protein TssB 21.6
BCAL0344 Putative type VI secretion system protein TssE 21.5
BCAL0813/rpoN Putative RNA polymerase sigma-54 factor 21.5
BCAL1046/plcN Putative non-hemolytic phospholipase C 21.7
BCAL3110/waaA 3-deoxy-D-manno-octulosonic-acid transferase involved in biosynthesis of O-antigen 21.6
BCAL3111/wbxY Protein involved in biosynthesis of O-antigen 21.6
BCAL3299/katB Peroxidase/catalase KatB 21.6
Chromossome 2
BCAM0207 Kinase associated to exopolysaccharide biosynthesis 1.6
BCAM0214 Glycosyltransferase associated to LPS biosynthesis 2.9
BCAM0219 Putative haemagglutinin-related autotransporter protein 1.5
BCAM0223 Putative haemagglutinin-related autotransporter protein 3.8
BCAM0240/cciR N-acylhomoserine lactone dependent regulatory protein 1.7
BCAS0296 Other potential surface polysaccharides 1.6
BCAM0338 Protein of unknown function 21.6
BCAM0339 Hypothetical protein 21.6
BCAM0408 Putative phospholipase C 22.2
BCAM2048/bcscN Type III secretion system protein 21.7
BCAM2050/bcscK Type III secretion system protein 21.7
BCAM2051/bcscJ Type III secretion system protein 21.7
BCAM2052 Protein of unknown function of the type III secretion system 21.7
BCAM2053 Protein of unknown function of the type III secretion system 22.8
BCAM2055/bcscC Type III secretion system protein 21.8
BCAM2056/bcscS Type III secretion system protein 21.8
BCAM2143/adhA Cable pilus associated adhesin protein 22.0
BCAM2169 Putative outer membrane autotransporter 22.4
BCAM2307/zmpB Zinc metalloprotease 23.5
Chromossome 3
BCAS0225/shvR Shiny variant regulator 1.5
BCAS0296 Other potential surface polysaccharides 1.6
BCAS0305 Putative lipoprotein 2.2
BCAS0236 Putative haemagglutinin-related autotransporter protein 22.3
BCAS0293/aidA Nematocidal protease AidA 29.1
BCAS0409/zmpA Zinc metalloprotease ZmpA 27.8
The dataset of genes differently transcribed in IST439 and IST4113 was searched for genes known to be involved in virulence using the compilation made by Holden
et al., 2009 and Loutet and Valvano, 2010 [78]. To confirm the results from the microarray analysis, the transcript levels from a number of genes listed was compared by
quantitative real time RT- PCR (qRT-PCR).
doi:10.1371/journal.pone.0028831.t003
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be up-regulated in IST4113 which exhibits a higher growth
efficiency under iron limitation [15]. These up-regulated genes
included genes required for the biosynthesis of the iron side-
rophore ornibactin and several TonB-dependent receptors that are
required for the uptake of iron-siderophore complexes. Iron-
acquisition mechanisms are considered key factors for the
successful colonization of human infecting bacteria as the level
of free iron within mammals is well below the one required for
optimal bacterial growth [59]. In particular, ornibactin biosyn-
thesis is essential for long-term B. cenocepacia infections of rat lungs
[41]. The use of the heme group released upon proteolytic
degradation of heme-containing proteins (e.g. lactoferrin, ferritin
and hemoglobin) is also considered a crucial mechanism by which
human infecting bacteria scavenge iron [59] and B. cenocepacia is
able to use ferritin as an iron source [60]. Significantly, the huvA
and hmuS genes, involved in the uptake and degradation of heme,
are up-regulated in the IST4113 variant, compared to IST439.
Interestingly, one of the exoproteases found to be up-regulated in
the IST4113 variant, LepA, was recently demonstrated to be
involved in the ability of P. aeruginosa to use hemoglobin as a
carbon and iron source [61].
Microaerobic respiration was recently demonstrated to be the
predominant mode of P. aeruginosa growth in the CF lung [62] and
proposed to occur during B. cenocepacia chronic CF infections [15].
The increased transcript levels from genes encoding CioAB
cytochrome subunits, which are known to be used for electron
transference to oxygen under microaerophilic conditions [62], and
the lower transcript levels from genes encoding cytochromes used
for electron transfer under aerobic conditions (cytochromes o and
bd subunits) registered in the IST4113 variant, reinforces the
concept that microaerobic respiration occurs and B. cenocepacia
adapts to growth in the airways of CF patients during long-term
colonization and the progression of the disease accompanied by
deterioration of pulmonary function.
A number of genes considered as B. cenocepacia virulence factors
do have an altered transcription in the two variants (Table 3). In
particular, the haemagglutinin autotransporters BCAM0219 and
BCAM0223, proposed to be involved in B. cenocepacia adhesion to
the epithelial lung tissue [63], are up-regulated in IST4113.
BCAM0219 and BCAM0223 encode two orthologues of the
surface-attached collagen-binding protein YadA from Yersinia
species that, together with BCAM0224, form an adhesin-cluster
considered an extension of the cci pathogenicity island [63].
Notably, the expression of BCAM0223 increases B. cenocepacia
survival in the lungs of a CF rat model [64]. Other responses
favouring the adhesion of B. cenocepacia to epithelial cells are also
suggested to be improved in IST4113 cells, based on the results of
the microarray analysis, including the increased expression of
genes involved in biosynthesis and assembly of the flagella and the
production of a smaller O-antigen chain in the LPS [45,65]. B.
cenocepacia attaches to the mucin present in the airways of CF
patients through the expression of lectins that recognize protrud-
ing glycans [42,43,44]. Four lectin-encoding genes were found to
be differently transcribed in IST439 and IST4113: bclB and bclC
are up-regulated in IST4113, while bclA and BCAS0292 are down-
regulated. BclC is involved in the recognition of fucosylated
glycans while BclA is involved in the recognition of mannosylated
glycans [42,43]. Compared to the mucin of healthy individuals,
the mucin recovered from CF patients has a much higher content
of fucosylated sugars and almost no mannose [66], consistent with
the adaptive transcriptional response registered for IST4113 cells.
The virulence factors suggested to be expressed at lower levels in
IST4113 include the exoproteases ZmpA and ZmpB, the cable pili
adhesin AdhA, several proteins of type III and type VI-secretion
systems and the phospholipases plcN and BCAM0408 (Table 3).
Since these proteins can be recognized by the host immune
system, either because they are secreted or because they are
present at the cell surface, their decreased amount may help B.
cenocepacia to circumvent the activity of the host immune system, as
proposed for P. aeruginosa [6,8,67].
The IST4113 clonal variant is more resistant than the first
isolate to a wide variety of clinically relevant antibiotics with very
different biological targets [15,16]. Based on the results of this
study, the mechanisms underlying this enhanced antibiotic
resistance of IST4113 cells involve a higher active drug export
capacity related with the increased transcription from various
genes encoding drug efflux pumps in IST4113 (Table 2). Among
these drug pump-encoding genes up-regulated in IST4113 are
three subunits of the RND-efflux transporter mdtABC (known as
RND6) and one component (bpeA) of the RND efflux pump
BCAL2821-BCAL2820-bpeA pump (known as RND4). The tran-
script levels of BCAL2821 and BCAL2820 genes that do not belong
to the same transcriptional unit of bpeA [30], were identical in the
two variants. RND4 efflux pump is involved in the extrusion of
gentamicin, tobramycin and ciprofloxacin in B. cenocepacia J2315
[27,29,68], three antibiotics to which IST4113 is less susceptible
than IST439 [15,16]. No substrates had been identified for the
MdtABC pump or for the other putative drug efflux pumps found
to be up-regulated in IST4113. The RND4 pump is highly
homologous to the P. aeruginosa drug pump MexXY-OprM,
demonstrated to have a role in the intrinsic and acquired
resistance of CF isolates of P. aeruginosa to aminoglycosides
[69,70]. The up-regulation of MexXY-OprM in response to
aminoglycosides and other protein synthesis inhibitors was related
with ribosomal activity, establishing a link between the efflux of
these drugs and translational machinery activity [71]. Interesting-
ly, more than eighty genes related with translation were found
among the set of genes up-regulated the IST4113 variant.
The alteration of the bacterial cell surface is another mechanism
contributing to the intrinsic and acquired resistance of Bcc
bacteria to antibiotics [2,31,32]. In particular, the down-regulation
of porine synthesis in CF isolates of B. cenocepacia resistant to
antibiotics was described [32]. Ten genes encoding porines were
found to be down-regulated in IST4113, including a few genes
encoding proteins highly homologous to porines demonstrated to
serve as channels for the entry of antibiotics in other Gram
negative bacteria. Several lipoproteins and proteins related with
LPS and peptidoglycan biosynthesis were also differently expressed
in IST439 and IST4113. These observations together with the
different morphology of the colonies formed by the two variants
(IST439 colonies are smooth and IST4113 colonies are rough
[16]) strongly suggest that they have a different cell surface, a
phenotypic trait that can contribute to the higher resistance of
IST4113 to antibiotics since the conversion from smooth to rough
LPS in P. aeruginosa results in a higher cell impermeability to
aminoglycosides [72].
Several transcriptional regulators were also found to be
transcribed at different levels in IST439 and IST4113. Among
these are CciR and ShvR, two transcription factors with a role in
quorum-sensing-mediated signalling and in the control of B.
cenocepacia genomic expression and pathogenesis [23,73,74,75].
Remarkably, 37 genes described as being activated by CciR and
57 genes documented to be repressed by this transcription factor
are present in the dataset of genes differently expressed in
IST4113, compared to IST439 (Supplementary Table S4).
Although ShvR plays a crucial role in the control of B. cenocepacia
genomic expression [75], there is no information on its target
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IST4113 also include a number of known targets of other
transcription factors (e.g. CepR) whose transcript levels were not
found to be significantly different in the two variants. All these
transcription regulators deserve further in depth studies to
elucidate their eventual role in genomic expression reprogram-
ming during long-term colonization under antibiotic therapy and
the progression of the disease.
The number of genes found to produce different mRNA levels
in IST439 and IST4113 was much higher than the number of
proteins previously found to be differently abundant in these two
isolates (1024 compared to 79, using the same 1.5-threshold level
and cells grown under identical conditions [16]). The limited
protein coverage of the 2-DE-based quantitative proteomic
analysis carried out failed to identify a number of relevant gene
expression differences that emerged from the present study but, in
general, the functional classes enriched in the datasets of
differently abundant proteins or transcripts coincided (Supple-
mentary Table S5). In particular, the up-regulation of genes/
proteins involved in translation, iron binding and uptake and in
the biogenesis of cell envelope and outer membrane in the
IST4113 variant, compared to IST439, was identified in the two
genome-wide expression analyses (Supplementary Tables S1, S2,
S3 and S5). However, the present study reveals a number of genes
that were ignored in the proteomic analysis and extends the
knowledge to genes of functional groups whose identification is not
possible through the quantitative proteomic approach used, as it is
the case of transmembrane solute transporters, in particular drug-
pumps, and to low expressed genes, namely those encoding
transcription regulators. The present transcriptomic analysis
together with the extensive phenotypic studies of serial isolates of
B. cenocepacia obtained during long-term colonization of the same
CF patient [15,16,76], is providing clues that strongly suggest a
genetic adaptation to the challenges exerted by the immune
system, antimicrobial therapy, nutrient availability and micro-
aerophilic conditions, leading to a higher antibiotic resistance and
bacterial persistence in the lungs. Understanding these mecha-
nisms is crucial for an improved therapeutic outcome of chronic
infections in CF patients.
Materials and Methods
Bacterial isolates and growth media
The two Burkholderia cenocepacia clinical isolates examined in this
study, IST439 and IST4113, were recovered from the sputum of
an anonymous CF patient, under surveillance at the CF Center of
Hospital of Santa Maria on January 1999 and on November 2001,
respectively [76]. The studies performed by our laboratory
involving the use of B. cenocepacia isolates collected from CF
patients followed at Hospital de Santa Maria performed have been
approved by the ethics committee of the Hospital. IST439 and
IST4113 isolates are two clonal variants characterized before
[15,16]. Bacterial growth was carried out in Luria Bertani (LB)
medium (Difco), at 37uC, with orbital agitation (250 rpm) or on
solid LB medium obtained by supplementation of the liquid LB
medium with 2% agar (Iberagar, Portugal).
Genome-wide transcriptomic analysis of B. cenocepacia
IST439 and IST4113 isolates
a) Growth conditions and RNA extraction. B. cenocepacia
IST439 and IST4113 were cultivated in LB liquid growth medium
until mid-exponential phase (OD640 nm 0.460.05) and then
diluted to a standardized OD640 nm of 0.260.05 in NaCl 0.9%
(w/v). These cell suspensions (100 ml) were plated onto LB agar
plates and then incubated for 24 h at 37uC. To reduce biological
variation, cells harvested from 8 independently prepared LB-agar
plates were mixed together and used for subsequent extraction of
total RNA. RNA extraction was made using the RiboPure kit
(Ambion) according with the manufacturer’s instructions. The
recovered RNA was treated for one hour with 10 U of DNaseI,
precipitated with 7.5 M lithium chloride and finally resuspended
in 100 mL of RNase-free water. The samples were concentrated to
a minimum of 1.25 mg/mL and the quality of the RNA was
assessed upon electrophoretic separation on a Bioanalyzer. Only
samples with RNA integrity numbers higher than 8.0 were used
for the subsequent microarray analysis.
b) Microarray hybridization and data analysis. The
custom-made 4644 K microarrays for B. cenocepacia as well as
the protocols used for RNA labelling, hybridization in the
microarray and fluorescence signal scanning were performed as
described before [24]. Briefly, 10 mg of total RNA collected from
IST439 and IST4113 isolates was used for cDNA synthesis and
subsequent labelling with Cy3 using the CyScribe Post-Labelling
Kit (GE Healthcare) and following the manufacturer’s
recommendations. Genomic DNA of B. cenocepacia J2315 strain
(1 mg) was labelled with Cy5 using the CyScribe Array CGH
Genomic DNA Labeling System (GE Healthcare) and used as
an internal control for the microarray hybridization. After
hybridization and scanning, the microarray image was analysed
using Agilent Feature Extraction software and only those probes
considered ‘‘Present’’ by the software were selected for further
analysis. Gene expression analysis was performed using
GeneSpring GX 7.3 (Agilent) and data were normalized using
the Affymetrix FE data normalization procedure recommended
for two-colour Agilent microarrays. For each sample, the intensity
measured for a given gene was divided by the value obtained in
the control channel value. Only those genes whose transcript levels
difference in IST439 and in IST4113 were equal or above 1.5-fold
were considered to be differentially transcribed in the two variants.
A one-way ANOVA analysis was performed over the gathered
data and only the genes having an associated p-value below 0.05
were considered for further analysis. The raw data of the
microarray analysis is MIAME compliant and was deposited in
the Array Express database (E-MTAB-809).
Quantitative RT-PCR
The transcript levels from a selected set of genes were compared
in IST439 and IST4113 using quantitative RT-real time PCR
(qRT-PCR). Bacterial growth and RNA extraction were per-
formed as described above for the microarray analysis. Synthesis
of cDNA was performed from 200 ng of total RNA using the
Reverse Transcription kit from Applied Biosystems. The cDNA
obtained was diluted (1:4) in RNase-free water and used as
template for the subsequent PCR step. This second step was
carried out in a Thermal Cycler Block (Applied Biosystems) and
SYBRH Green 7500 RT-PCR (Applied Biosystems) was used to
accompany the increase in fluorescence during DNA synthesis.
The primers used in gene amplifications were designed to exclude
cross-hybridizations and their sequence is available upon request.
Comparison of the intracellular accumulation of ethidium
bromide in IST439 and IST4113 cells
The quantitative comparison of the intracellular accumulation
of ethidium bromide inside IST439 and IST4113 cells was
estimated using the ethidium bromide agar screening method [77].
Isolated colonies of IST439 and IST4113 were cultivated in LB
liquid medium until mid-exponential phase (OD640 nm of
0.460.05), diluted in NaCl 0.9% to obtain a cell suspension with
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duplicate, onto the surface of LB plates supplemented with
ethidium bromide (concentrations ranging from 0 to 1.0 mg/L)
and the plates were incubated for 24 h at 37uC. One set of plates
was incubated for an additional period of 4 h at 37uC while the
other set was incubated for the same time at 4uC. The fluorescence
emitted by the bacterial mass in the plate was assessed in a UV
transilluminator (Bio-Rad Gel Doc XR System) and quantified
using the Quantity One software V 4.5.2 (Bio-Rad Laboratories).
Supporting Information
Table S1 Sub-set of genes found to be differently
transcribed (above or below 1.5-fold) in IST439 and
IST4113. The genes whose transcript levels in the IST4113
variant were above, or below, 1.5-fold the values attained in
IST439 were considered to be differently expressed in the two
variants and were selected for further analysis. The genes found to
be down-regulated in IST4113 are shaded in grey. The full list of
genes that have altered transcript levels in the two variants is
provided in Supplementary Tables S1 and S2. These genes were
grouped according with their biological function using the
functional clustering indicated in Figure 1.
(PDF)
Table S2 Full list of genes up-regulated (above 1.5-fold)
in B. cenocepacia IST4113, compared to IST439. The
genes whose transcript level in the B. cenocepacia IST4113 variant
were at least 1.5-fold higher than the levels attained in the IST439
were selected. The description of gene function is based on the
information available in the ‘‘Burkholderia Genome Database’’ and
in ‘‘KEGG Pathways’’ database and the functional clustering was
performed using the functional classes shown in Figure 1. Genes
specific of the AU1054 strain are shaded in grey.
(PDF)
Table S3 Full list of genes down-regulated (above 1.5-
fold) in B. cenocepacia IST4113, compared to IST439.
The genes whose transcript level in the B. cenocepacia IST4113
variant were at least 1.5-fold lower than the levels attained in
IST439 were selected. The description of gene function is based
on the information available in the ‘‘Burkholderia Genome
Database’’ and in ‘‘KEGG Pathways’’ database and the functional
clustering was performed using the functional classes shown in
Figure 1. Genes specific of the AU1054 strain are shaded in grey.
(PDF)
Table S4 List of genes having an altered expression in
B. cenocepacia variants IST439 and IST4113 that are
documented to be regulated by CciR. The microarray
dataset was searched for genes documented to be activated or
repressed by the CciR transcription factor using the results of
O’Grady et al., (2010).
(PDF)
Table S5 Proteins found in the membrane-enriched
fraction and in the cytosolic fraction whose content was
increased (above 1.5-fold) or decreased (below 0.7-fold)
in the proteome of B. cenocepacia IST4113 cells,
compared to the values registered in B. cenocepacia
IST439 (Madeira et al., 2011). The genes predicted to encode
these proteins are also indicated and those found to be differently
expressed in the two variants, based on the results of the
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